tiprankstipranks
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market
ARCT
Arcturus Therapeutics
RESEARCH TOOLSreports
Want to see ARCT full AI Analyst Report?

Arcturus Therapeutics (ARCT) Income Statement

2,168 Followers

Arcturus Therapeutics Income Statement

Last quarter (Q4 2025), Arcturus Therapeutics's total revenue was $3.08M, a decrease of -85.33% from the same quarter last year. In Q4, Arcturus Therapeutics's net income was $-29.08M. See Arcturus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 67.22M$ 138.39M$ 157.75M$ 205.75M$ 12.36M
Gross Profit
$ 64.20M$ 138.39M$ 157.75M$ 205.75M$ 12.36M
Operating Expenses
$ 139.15M$ 234.06M$ 235.95M$ 193.58M$ 215.21M
Depreciation and Amortization
$ 3.02M$ 3.54M$ 2.96M$ 1.53M$ 1.19M
EBITDA
$ -71.93M$ -77.40M$ -24.16M$ 13.70M$ -201.66M
Operating Income
$ -74.95M$ -95.67M$ -78.20M$ 12.18M$ -202.85M
Other Income/Expenses
$ 9.17M$ 14.72M$ 50.31M$ -1.53M$ -822.00K
Pretax Income
$ -65.78M$ -80.94M$ -27.89M$ 10.64M$ -203.67M
Net Income
$ -65.78M$ -80.94M$ -29.73M$ 9.35M$ -203.67M
Per Share Metrics
Basic EPS
$ -2.40$ -3.00$ -1.12$ 0.35$ -7.74
Diluted EPS
$ -2.40$ -3.00$ -1.12$ 0.35$ -7.74
Weighted Average Shares Outstanding
 27.39M 27.00M 26.63M 26.45M 26.32M
Weighted Average Shares Outstanding (Diluted)
 27.39M 27.00M 26.63M 27.09M 26.32M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History